| Literature DB >> 32134014 |
Shraddha Chakraborty1, Gauri Prasad1, Raman Kumar Marwaha2, Analabha Basu3, Nikhil Tandon4, Dwaipayan Bharadwaj5.
Abstract
Background & objectives: Obesity-mediated chronic inflammatory state is primarily governed by lifestyle and food habits in adolescents and marked by alterations in the level of various inflammatory markers. This cross-sectional study was aimed to compare the inflammatory status of healthy Indian adolescents vis-à-vis their obesity profile. The inflammatory state of urban adolescents attending private and government-funded schools, and the relationship between inflammatory marker levels and anthropometric indices in the study participants from both groups were examined.Entities:
Keywords: Adipocytokines; CRP; Indian adolescents; inflammatory markers; juvenile health; lifestyle changes; obesity; socio-economic status
Mesh:
Substances:
Year: 2020 PMID: 32134014 PMCID: PMC7055163 DOI: 10.4103/ijmr.IJMR_1631_18
Source DB: PubMed Journal: Indian J Med Res ISSN: 0971-5916 Impact factor: 2.375
Comparison of anthropometric indices and plasma cytokine levels among adolescents from private and government schools
| Parameters | School type | |||
|---|---|---|---|---|
| Private | Government | |||
| Median or n | P25, P75 or % | Median or n | P25, P75 or % | |
| Total samples (n) | 3643 | 795 | ||
| Male (n and %) | 1600 | 43.9 | 271 | 34.1 |
| Age (yr) | 13*** | 12, 15 | 14 | 13,15 |
| BMI (kg/m2) | 19.3*** | 16.8, 22.9 | 17.5 | 15.9,19.3 |
| Overweight (n and %) | 704 | 19.3 | 37 | 4.7 |
| Obese (n and %) | 284 | 7.8 | 7 | 0.9 |
| Waist circumference (cm) | 71.5*** | 64.5, 80.0 | 64.0 | 60.0,69.0 |
| Hip circumference (cm) | 85.0*** | 78.5, 93.0 | 79.0 | 73.0,83.5 |
| WHR | 0.84*** | 0.80, 0.89 | 0.82 | 0.78,0.86 |
| Plasma adiponectin (µg/ml) | 3.9*** | 2.8, 7.9 | 10.3 | 6.7,15.1 |
| Plasma leptin (ng/ml) | 3.2* | 1.8, 9.1 | 3.6 | 1.3,8.2 |
| Plasma resistin (ng/ml) | 4.5*** | 3.0, 6.2 | 6.7 | 5.4,8.8 |
| Plasma CRP (mg/l) | 0.5*** | 0.2, 1.4 | 0.3 | 0.1,0.8 |
P*<0.05, ***<0.001 compared to respective values in government schoolchildren. P25, 25th percentile; P75, 75th percentile; WHR, waist-to-hip ratio; CRP, C-reactive protein; BMI, body mass index
Comparison of plasma cytokine levels across different groups in the study population
| Plasma cytokine levelsa | n | Plasma adiponectin (µg/ml) | Plasma leptin (ng/ml) | Plasma resistin (ng/ml) | Plasma CRP (mg/l) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | P25, P75 | Pa,b | Median | P25, P75 | Pa,b | Median | P25, P75 | Pa,b | Median | P25, P75 | Pa,b | ||
| Total samples | 4438 | 4.7 | 3.0, 9.5 | - | 3.3 | 1.7, 8.9 | - | 4.9 | 3.4, 6.7 | - | 0.5 | 0.2, 1.3 | - |
| Obesity status | |||||||||||||
| Normal | 3406 | 5.0 | 3.0, 10.1 | <0.001 | 2.9 | 1.2, 5.8 | <0.001 | 4.9 | 3.3, 6.7 | 0.420 | 0.4 | 0.2, 0.9 | <0.001 |
| Overweight | 741 | 4.3 | 2.7, 8.3 | 8.7 | 3.3, 17.7 | 5.0 | 3.5, 6.9 | 1.2 | 0.5, 2.4 | ||||
| Obese | 291 | 3.7 | 2.5, 6.0 | 15.4 | 5.0, 27.2 | 5.3 | 3.6, 6.6 | 2.0 | 0.8, 3.9 | ||||
| Gender | |||||||||||||
| Male | 1871 | 3.8 | 2.8, 7.6 | <0.001 | 2.3 | 0.7, 4.1 | <0.001 | 4.5 | 3.0, 6.3 | <0.001 | 0.5 | 0.2, 1.3 | 0.272 |
| Female | 2567 | 5.7 | 3.2, 11.0 | 4.6 | 2.8, 11.6 | 5.2 | 3.6, 6.9 | 0.5 | 0.2, 1.2 | ||||
| Age (yr) | |||||||||||||
| 10-<11 | 139 | 4.5 | 2.9, 8.6 | <0.001 | 3.8 | 1.4, 8.9 | <0.01 | 4.5 | 3.2, 6.3 | <0.01 | 0.6 | 0.2, 1.6 | <0.001 |
| 11-<12 | 507 | 4.4 | 2.9, 8.4 | 3.0 | 1.7, 6.4 | 4.5 | 2.9, 6.5 | 0.5 | 0.2, 1.5 | ||||
| 12-<13 | 726 | 5.6 | 3.3, 10.2 | 3.5 | 1.9, 9.0 | 4.8 | 3.7, 6.3 | 0.5 | 0.2, 1.2 | ||||
| 13-<14 | 851 | 4.9 | 3.1, 9.5 | 3.4 | 1.8, 8.8 | 4.8 | 3.5, 6.5 | 0.4 | 0.2, 1.1 | ||||
| 14-<15 | 854 | 4.3 | 2.9, 9.1 | 3.2 | 1.6, 8.4 | 5.0 | 3.2, 6.8 | 0.5 | 0.2, 1.1 | ||||
| 15-<16 | 595 | 4.3 | 2.8, 8.7 | 3.2 | 1.6, 9.1 | 5.1 | 3.3, 7.0 | 0.5 | 0.2, 1.3 | ||||
| 16-<17 | 477 | 4.7 | 2.8, 10.1 | 3.7 | 1.8, 10.5 | 5.3 | 3.5, 7.3 | 0.6 | 0.2, 1.4 | ||||
| 17-<18 | 289 | 5.3 | 3.0, 10.5 | 3.5 | 1.3, 10.8 | 5.3 | 3.0, 7.0 | 0.7 | 0.2, 1.6 | ||||
aKruskal-Wallis test used to analyze differences in cytokine levels among the study participants of different obesity status and age; bWilcoxon-Mann-Whitney test used to analyze differences in cytokine levels among male and female study participants
Comparison of anthropometric indices and plasma cytokine levels among severely lean and obese study participants
| Parameters | Lean (BMI <15 kg/m2) | Obese (BMI >30 kg/m2) | ||
|---|---|---|---|---|
| Median or n | P25, P75 or % | Median or n | P25, P75 or % | |
| Total samples (n) | 398 | 123 | ||
| From private school (n and %) | 301 | 75.6 | 122 | 99.2 |
| Age (yr) | 12*** | 11, 14 | 15 | 14, 16 |
| BMI (kg/m2) | 14.3*** | 13.6, 14.7 | 31.5 | 30.7, 33.7 |
| Waist circumference (cm) | 58.5*** | 55.2, 62.0 | 96.0 | 88.0, 103.0 |
| Hip circumference (cm) | 71.0*** | 67.0, 75.0 | 110.0 | 106.0, 114.0 |
| WHR | 0.83*** | 0.79, 0.87 | 0.86 | 0.82, 0.94 |
| Plasma adiponectin (µg/ml) | 4.6*** | 3.1, 10.7 | 3.3 | 2.0, 5.6 |
| Plasma leptin (ng/ml) | 1.2*** | 0.4, 2.8 | 17.1 | 4.0, 36.1 |
| Plasma resistin (ng/ml) | 4.7 | 3.0, 6.5 | 5.3 | 3.7, 6.6 |
| Plasma CRP (mg/l) | 0.3*** | 0.1, 0.6 | 1.9 | 0.6, 4.3 |
Wilcoxon-Mann-Whitney test used to test for difference among participants, based on severely lean and obese category.
***P<0.001. P25, 25th percentile; P75, 75th percentile; WHR, waist-to-hip ratio; CRP, C-reactive protein; BMI, body mass index
Comparison of plasma cytokine levels among severely lean and obese adolescents stratified by gender
| Plasma cytokine levels | Males | Females | ||
|---|---|---|---|---|
| Lean (BMI <15 kg/m2) (n=231) | Obese (BMI >30 kg/m2) (n=47) | Lean (BMI <15 kg/m2) (n=173) | Obese (BMI >30 kg/m2) (n=82) | |
| Median (P25, P75) | Median (P25, P75) | |||
| Plasma adiponectin (µg/ml) | 4.42 (2.99, 9.53)*** | 2.73 (1.94, 4.43) | 4.93 (3.3, 12.42)*** | 3.92 (2.34, 5.98) |
| Plasma leptin (ng/ml) | 0.63 (0.28, 1.4)*** | 7.16 (3.4, 18.2) | 2.1 (1.3, 3.7)*** | 25.02 (9.51, 41.14) |
| Plasma resistin (ng/ml) | 4.32 (2.82, 5.83) | 4.25 (3.57, 6.04) | 5.33 (3.75, 7.39) | 5.47 (3.77, 7.02) |
| Plasma CRP (mg/l) | 0.35 (0.13, 0.6)*** | 2.16 (0.89, 5.1) | 0.28 (0.12, 0.62)*** | 1.57 (0.56, 3.34) |
***P<0.001 compared to obese group in the respective category
Comparison of plasma cytokine levels among severely lean and obese adolescents stratified by age
| Age (yr) | Category (BMI, kg/m2) | Median (P25, P75) | |||
|---|---|---|---|---|---|
| Plasma adiponectin (µg/ml) | Plasma leptin (ng/ml) | Plasma resistin(ng/ml) | Plasma CRP (mg/l) | ||
| 12-<13 | Lean (<15), n=96 | 6.67 (3.55, 12.59) | 1.39 (0.51, 2.45) | 4.91 (3.35, 6.41) | 0.27 (0.1, 0.48) |
| Obese (>30), n=11 | 3.51 (2.56, 5.73)* | 16.97 (6.23, 19.94)*** | 3.93 (2.81, 5.3) | 0.61 (0.26, 4)* | |
| 13-<14 | Lean (<15), n=64 | 4.1 (3.04, 7.95) | 1.39 (0.62, 2.95) | 4.79 (3, 6.16) | 0.22 (0.11, 0.49) |
| Obese (>30), n=17 | 5.27 (4.36, 6.59) | 26.75 (16.25, 41.38)*** | 5.92 (4.22, 7.1) | 1.45 (0.81, 3.79)*** | |
| 14-<15 | Lean (<15), n=54 | 4.85 (3.12, 10.770) | 0.92 (0.31, 3) | 4.95 (3.66, 8.99) | 0.32 (0.11, 0.83) |
| Obese (>30), n=27 | 3.57 (1.85, 5.56)** | 25.69 (4, 38.59)*** | 5.49 (3.9, 8.1) | 2.54 (1.14, 6.13)*** | |
| 15-<16 | Lean (<15), n=30 | 5.62 (2.76, 10.78) | 1.1 (0.29, 2.02) | 5.56 (3.81, 7.26) | 0.36 (0.15, 0.96) |
| Obese (>30), n=19 | 3.28 (2.37, 5.31) | 18.19 (6.46, 26.98)*** | 4.62 (4.3, 5.73) | 0.7 (0.37, 3.53)* | |
| 16-<17 | Lean (<15), n=9 | 3.35 (2.97, 5.43) | 0.75 (0.2, 2) | 5.8 (3.53, 6.44) | 0.46 (0.42, 0.61) |
| Obese (>30), n=26 | 3.1 (2.38, 4.77) | 9.94 (3.42, 34.88)*** | 4.6 (3.43, 6.4) | 1.44 (1.09, 4.14)** | |
| 17-<18 | Lean (<15), n=8 | 5.1 (3.6, 15.14) | 4.38 (1.72, 5.83) | 7.87 (4.77, 10.02) | 0.35 (0.1, 0.58) |
| Obese (>30), n=20 | 2.37 (1.84, 3.46)** | 10.8 (4.35, 21.66)* | 5.5 (3.56, 6.46) | 2.27 (1.09, 2.94)** | |
P*<0.05, **<0.01, ***<0.001 compared to lean group in the respective category
Linear regression analysis of plasma cytokine and C-reactive protein levels with various adiposity indices, for private schoolgoing adolescents
| Parameters (n=3643) | Plasma adiponectin (µg/ml) | Plasma leptin (ng/ml) | Plasma resistin (ng/ml) | Plasma CRP (mg/l) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| βa | 95% CIa | βa | 95% CIa | βa | 95% CIa | βa | 95% CIa | |||||
| Age (yr) | −0.02 | −0.18, 0.04 | 0.199 | −0.13 | −0.81, −0.53 | <0.001 | 0.05 | 0.03, 0.22 | <0.01 | −0.11 | −0.12, −0.06 | <0.001 |
| Gender | 0.03 | −0.02, 0.74 | 0.065 | 0.26 | 4.33, 5.29 | <0.001 | −0.05 | −0.78, −0.11 | <0.05 | −0.02 | −0.18,0.04 | 0.182 |
| BMI (kg/m2) | −0.32 | −0.47, −0.31 | <0.001 | 0.48 | 0.88, 1.08 | <0.001 | 0.07 | 0.00, 0.14 | <0.05 | 0.13 | 0.02,0.07 | <0.001 |
| Waist circumference (cm) | −0.30 | −0.30, 0.01 | 0.071 | 0.07 | −0.15, 0.27 | 0.598 | 0.24 | −0.04, 0.24 | 0.171 | 0.28 | −0.01,0.08 | 0.095 |
| Hip circumference (cm) | 0.29 | 0.01, 0.28 | <0.05 | −0.01 | −0.19,0.17 | 0.941 | −0.24 | −0.22, 0.02 | 0.091 | 0.03 | −0.03,0.04 | 0.828 |
| WHR | 0.17 | 0.26, 27.28 | <0.05 | −0.02 | −20.46, 15.75 | 0.799 | −0.19 | −24.81, −0.84 | <0.05 | 0.02 | −3.48,4.19 | 0.856 |
| Plasma adiponectin (µg/ml) | - | - | - | 0.24 | 0.36, 0.44 | <0.001 | 0.15 | 0.10, 0.15 | <0.001 | −0.05 | −0.02, −0.01 | <0.01 |
| Plasma leptin (ng/ml) | 0.38 | 0.20, 0.25 | <0.001 | - | - | - | 0.20 | 0.08, 0.12 | <0.001 | 0.06 | 0.00,0.02 | <0.01 |
| Plasma resistin (ng/ml) | 0.14 | 0.12, 0.20 | <0.001 | 0.12 | 0.18, 0.28 | <0.001 | - | - | - | −0.06 | −0.03, −0.01 | <0.001 |
| Plasma CRP (mg/l) | −0.05 | −0.29, −0.06 | <0.01 | 0.04 | 0.08, 0.39 | <0.01 | −0.07 | −0.31, −0.10 | <0.001 | - | - | - |
| Constant | −1.73 | −16.53 | 13.81 | −1.62 | ||||||||
aValues are coefficient regression β (95% CI) by multiple linear regression analysis. Categorical variable: Male as reference for gender; all the cytokine concentrations were inverse normalized
Linear regression analysis of plasma cytokine and C-reactive protein levels with various adiposity indices, for government schoolgoing adolescents
| Parameters (n=795) | Plasma adiponectin (µg/ml) | Plasma leptin (ng/ml) | Plasma resistin (ng/ml) | Plasma CRP (mg/l) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| βa | 95% CIa | βa | 95% CIa | βa | 95% CIa | βa | 95% CIa | |||||
| Age (yr) | 0.07 | −0.05, 0.38 | 0.123 | −0.15 | −0.98, −0.35 | <0.001 | −0.03 | −0.20, 0.11 | 0.533 | −0.03 | −0.09, 0.04 | 0.538 |
| Gender | 0.18 | 0.95, 2.59 | <0.001 | 0.28 | 3.71, 6.10 | <0.001 | 0.05 | −0.25, 0.95 | 0.254 | −0.08 | −0.51, −0.01 | <0.05 |
| BMI (kg/m2) | −0.03 | −0.24, 0.15 | 0.625 | 0.09 | −0.03, 0.55 | 0.083 | −0.12 | −0.29, −0.00 | <0.05 | 0.22 | 0.06, 0.18 | <0.001 |
| Waist circumference (cm) | −0.03 | −0.52, 0.48 | 0.940 | −0.32 | −1.12, 0.38 | 0.336 | 0.28 | −0.24, 0.50 | 0.484 | 0.44 | −0.06, 0.24 | 0.242 |
| Hip circumference (cm) | −0.16 | −0.52, 0.33 | 0.663 | 0.65 | 0.05, 1.32 | <0.05 | −0.09 | −0.35, 0.27 | 0.793 | −0.29 | −0.19, 0.08 | 0.405 |
| WHR | 0.01 | −37.38, 39.20 | 0.963 | 0.27 | −23.44, 91.14 | 0.246 | −0.22 | −39.37, 16.37 | 0.418 | −0.20 | −16.25, 7.06 | 0.439 |
| Plasma adiponectin (µg/ml) | - | - | - | 0.01 | −0.09, 0.12 | 0.821 | −0.08 | −0.11, −0.01 | <0.05 | 0.07 | 0.00, 0.04 | 0.057 |
| Plasma leptin (ng/ml) | 0.01 | −0.04, 0.05 | 0.821 | - | - | - | 0.08 | −0.00, 0.07 | 0.064 | 0.06 | −0.00, 0.03 | 0.155 |
| Plasma resistin (ng/ml) | −0.08 | −0.21, −0.01 | <0.05 | 0.06 | −0.01, 0.28 | 0.064 | - | - | - | −0.02 | −0.04, 0.02 | 0.624 |
| Plasma CRP (mg/l) | 0.07 | −0.01, 0.46 | 0.057 | 0.05 | −0.10, 0.60 | 0.155 | −0.02 | −0.21, 0.13 | 0.624 | - | - | - |
| Constant | 16.08 | −57.03 | 16.44 | 1.27 | ||||||||
aValues are coefficient regression β [95% confidence interval (CI)] by multiple linear regression analysis. Categorical variable: Male as reference for gender; all the cytokine concentrations were inverse normalized
Metabolic profiles of normal-weight urban Indian adolescents
| Trait | Normal-weight adolescents (n=3406), median (P25, P75) | |
|---|---|---|
| Male (n=1455) | Female (n=1951) | |
| Age (yr) | 13 (12, 14.6)* | 14 (12, 15) |
| BMI (kg/m2) | 16.98 (15.55, 18.78)*** | 18.31 (16.5, 20.1) |
| Waist circumference (cm) | 68.5 (64, 74) | 65 (60, 70) |
| Hip circumference (cm) | 81 (76, 86)*** | 83 (78.3, 87) |
| Fasting glucose (mg/dl) | 87 (79.3, 94)*** | 83.8 (76.2, 91) |
| Fasting Insulin (pmol/l) | 45.1 (30.52, 65.2)*** | 56.26 (39.3, 78.4) |
| HOMA-IR | 1.38 (0.93, 2.05)*** | 1.67 (1.2, 2.4) |
| Total cholesterol (mg/dl) | 138 (122.6, 155.7)*** | 141.88 (127, 158.9) |
| High-density cholesterol (mg/dl) | 44.85 (40.39, 50.32)*** | 46.72 (41.8, 54.2) |
| Low-density cholesterol (mg/dl) | 81.9 (69, 92) | 82 (69.2, 94) |
| Triglycerides (mg/dl) | 86 (62.9, 108.2) | 87.8 (62, 116) |
P*<0.05, ***<0.001 compared to females. HOMA-IR, Homeostatic Model Assessment of Insulin Resistance
Metabolic profiles of normal-weight adolescents based on lower and upper quartiles of plasma adpocytokines and C-reactive protein (n=3406)
| Metabolic syndrome risk factors | Plasma cytokinecategories | |||||||
|---|---|---|---|---|---|---|---|---|
| Low adiponectin (≤3.02 µg/ml) (n=822) | High adiponectin (≥10.11 µg/ml) (n=825) | Low leptin (≤1.25 ng/ml) (n=822) | High leptin (≥5.85 ng/ml) (n=824) | Low resistin (≤3.31 ng/ml) (n=812) | High resistin (≥6.73 ng/ml) (n=818) | Low CRP (≤0.16 mg/l) (n=822) | High CRP (≥0.86 mg/l) (n=842) | |
| Median (P25, P75) | Median (P25, P75) | Median (P25, P75) | Median (P25, P75) | |||||
| Waist circumference (cm) | 68.5 (63, 74.5)*** | 65 (60, 70) | 64.5 (60, 69)*** | 69 (63.5, 74) | 68.5 (63, 74.5)*** | 65.5 (61, 71) | 64 (59, 69)*** | 70 (64, 76) |
| Hip circumference (cm) | 82 (76.5, 88)*** | 80 (74, 85) | 78 (72, 83)*** | 84 (80, 89) | 82 (76, 87.5)** | 81 (75.5, 86) | 79 (74, 84)*** | 83 (78, 89) |
| Fasting glucose (mg/dl) | 82 (72.2, 90.8)*** | 87 (80.5, 93) | 85 (76.3, 92)*** | 87 (81, 92.9) | 77.8 (70.7, 87.4)*** | 87 (81, 93.9) | 89 (83, 96)*** | 83 (73.8, 91) |
| Fasting insulin(pmol/l) | 56.3 (38.1, 84.5)*** | 50.4 (33.4, 68.4) | 41.8 (28.5, 59.4)*** | 55.8 (38.9, 76.3) | 54.8 (39, 80.01)** | 50.4 (35.3, 70.1) | 47.7 (33.2, 65.3)*** | 55.6 (37.6, 80.1) |
| HOMA-IR | 1.64 (1.12, 2.46)*** | 1.53 (1.02, 2.13) | 1.23 (0.83, 1.8)*** | 1.71 (1.19, 2.41) | 1.59 (1.12, 2.25) | 1.55 (1.07, 2.25) | 1.5 (1, 2.1)** | 1.62 (1.12, 2.38) |
| Total cholesterol (mg/dl) | 143.8 (125.9, 162.3)*** | 138 (125.2, 152.7) | 136 (120.4, 152)*** | 145 (130, 163) | 139.7 (123.2, 157.8) | 140 (125.2, 154.6) | 141 (126, 159.1) | 141.2 (125, 160.5) |
| High-density cholesterol (mg/dl) | 46 (39.8, 53.4)** | 46 (43, 53.7) | 45.2 (40.6, 52.4)* | 46 (42, 52) | 46.3 (40.9, 54.2) | 46 (42, 52.8) | 46 (41, 53.04)*** | 45 (40, 51) |
| Low-density cholesterol (mg/dl) | 81.7 (69.7, 96.5)* | 81.7 (69, 91.9) | 79.6 (66.1, 91)*** | 84 (72, 95.2) | 82.3 (69.2, 94.1) | 82 (69, 93) | 82 (71, 94) | 82.6 (69.4, 94.1) |
| Triglycerides (mg/dl) | 80.8 (60.8, 113)* | 85 (58.5, 101) | 81 (60.5, 103)*** | 92.7 (66.9, 120.3) | 78 (57.9, 106.3)** | 86 (62.6, 107) | 92 (72.9, 123)*** | 87.4 (61.5, 116) |
P*<0.05, **<0.01, ***<0.001 compared to high level category in the respective groups